Capecitabine and oxaliplatin (XELOX) is safe and effective in patients with advanced gastric cancer

被引：16

作者：

Quek, Richard ^{[1
]}

Lim, Wan Teck ^{[1
]}

Foo, Kian Fong ^{[1
]}

Koo, Wen Hsin ^{[1
]}

A-Manaf, Afidah ^{[1
]}

Toh, Han Chong ^{[1
]}

机构：

[1] Natl Canc Ctr, Dept Med Oncol, Singapore 169610, Singapore

来源：

ACTA ONCOLOGICA | 2007年 / 46卷 / 07期

关键词：

D O I：

10.1080/02841860701253060

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

引用

收藏

页码：1032 / 1034

页数：3

相关论文

共 13 条

[1]

Phase II trial of biweekly infusional fluorouracil, folinic acid, and oxaliplatin in patients with advanced gastric cancer [J].

Al-Batran, SE ;

Atmaca, A ;

Hegewisch-Becker, S ;

Jaeger, D ;

Hahnfeld, S ;

Rummel, MJ ;

Seipelt, G ;

Rost, A ;

Knuth, JOA ;

Jaeger, E .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (04) :658-663

[2]

XELOX (capecitabine plus oxaliplatin):: Active first-line therapy for patients with metastatic colorectal cancer [J].

Cassidy, J ;

Tabernero, J ;

Twelves, C ;

Brunet, R ;

Butts, C ;

Conroy, T ;

Debraud, F ;

Figer, A ;

Grossmann, J ;

Sawada, N ;

Schöffski, P ;

Sobrero, A ;

Van Cutsem, E ;

Diaz-Rubio, E .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (11) :2084-2091

[3]

PHASE-I TRIAL OF 5-DAY CONTINUOUS VENOUS INFUSION OF OXALIPLATIN AT CIRCADIAN RHYTHM-MODULATED RATE COMPARED WITH CONSTANT RATE [J].

CAUSSANEL, JP ;

LEVI, F ;

BRIENZA, S ;

MISSET, JL ;

ITZHAKI, M ;

ADAM, R ;

MILANO, G ;

HECQUET, B ;

MATHE, G .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (12) :1046-1050

[4]

Cunningham D, 2006, J CLIN ONCOL, V24, p182S

[5]

Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer [J].

Glimelius, B ;

Ekstrom, K ;

Hoffman, K ;

Graf, W ;

Sjoden, PO ;

Haglund, U ;

Svensson, C ;

Enander, LK ;

Linne, T ;

Sellstrom, H ;

Heuman, R .

ANNALS OF ONCOLOGY, 1997, 8 (02) :163-168

[6]

A systematic overview of chemotherapy effects in gastric cancer [J].

Janunger, KG ;

Hafström, L ;

Nygren, P ;

Glimelius, B .

ACTA ONCOLOGICA, 2001, 40 (2-3) :309-326

[7]

Oxaliplatin and capecitabine in patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction and gastric cardia: a phase II study from the North Central Cancer Treatment Group [J].

Jatoi, A ;

Murphy, BR ;

Foster, NR ;

Nikcevich, DA ;

Alberts, SR ;

Knost, JA ;

Fitch, TR ;

Rowland, KM .

ANNALS OF ONCOLOGY, 2006, 17 (01) :29-34

[8]

Phase II study of oxaliplatin, fluorouracil, and folinic acid in locally advanced or metastatic gastric cancer patients [J].

Louvet, C ;

André, T ;

Tigaud, JM ;

Gamelin, E ;

Douillard, JY ;

Brunet, R ;

François, E ;

Jacob, JH ;

Levoir, D ;

Taamma, A ;

Rougier, P ;

Cvitkovic, E ;

de Gramont, A .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (23) :4543-4548

[9]

Moiseyenko VM, 2005, J CLIN ONCOL, V23, p308S

[10]

Incidence of cardiotoxicity with the oral fluoropyrimidine capecitabine is typical of that reported with 5-fluorouracil [J].

Van Cutsem, E ;

Hoff, PM ;

Blum, JL ;

Abt, M ;

Osterwalder, B .

ANNALS OF ONCOLOGY, 2002, 13 (03) :484-485